Biotechnology · Healthcare
Chief Accounting Officer
2026-02-01–present
Chief Accounting Officer
AN2 Therapeutics, Inc. (ANTX)Equibles does not estimate personal net worth.
Get an email with a short summary when AN2 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANTX alertsSarah Williams is recorded as Chief Accounting Officer at AN2 Therapeutics, Inc. (ANTX) since February 1, 2026. AN2 Therapeutics, Inc. reported in an 8-K filed January 29, 2026 that Sarah Williams was appointed Vice President, Controller and Principal Accounting Officer, effective February 1, 2026. AN2 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AN2 Therapeutics, Inc. includes Eric Easom (CEO and Board Member), Lucy Day (CFO and Chief Accounting Officer), Josh Eizen (COO) and 7 others.
“On January 26, 2026, the Board of Directors (the “Board”) of AN2 Therapeutics, Inc. (the “Company”) appointed Sarah Williams as Vice President, Controller and Principal Accounting Officer of the Company.”
2026-02-01–present
Biotechnology · Healthcare
Chief Accounting Officer
2026-02-01–present